For instance, Baldeviano et al. reported that IL-17A promotes the development of dilated cardiomyopathy and blockade of IL-17A attenuates cardiac fibrosis and ameliorate ventricular function in experimental myocarditis [8]. Here, IL17A is linked to dilated cardiomyopathy.